Health Care & Life Sciences » Pharmaceuticals | Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
27,356.00
28,370.00
15,577.00
1,803.00
311.00
586
Cost of Goods Sold (COGS) incl. D&A
705.00
-
-
-
-
586
Gross Income
26,651.00
-
-
-
-
586
SG&A Expense
16,939.00
16,526.00
23,900.00
25,756.00
32,237.00
31,430
EBIT
9,712.00
11,106.00
9,361.00
24,817.00
32,575.00
32,016
Unusual Expense
11.00
-
-
-
-
1,602
Non Operating Income/Expense
2,035.00
1,344.00
6,933.00
1,316.00
1,394.00
701
Interest Expense
64.00
-
-
-
-
1,394
Pretax Income
12,032.00
13,018.00
15,752.00
22,997.00
30,704.00
34,497
Consolidated Net Income
3,833.00
13,018.00
15,752.00
22,997.00
30,704.00
34,497
Net Income
3,833.00
13,018.00
15,752.00
22,997.00
30,704.00
34,497
Net Income After Extraordinaries
3,833.00
13,018.00
15,752.00
22,997.00
30,704.00
34,497
Net Income Available to Common
3,833.00
13,018.00
15,752.00
22,997.00
30,704.00
31,616
EPS (Basic)
0.27
4.11
1.10
1.48
1.71
1.63
Basic Shares Outstanding
14,179.70
3,165.60
14,281.80
15,493.50
17,985.10
19,425.70
EPS (Diluted)
0.27
3.28
1.10
1.48
1.72
1.63
Diluted Shares Outstanding
14,179.70
3,963.80
14,281.80
15,493.50
18,001.80
19,425.70
EBITDA
10,417.00
11,844.00
8,323.00
23,953.00
31,926.00
31,430
Non-Operating Interest Income
338.00
568.00
542.00
504.00
477.00
1,216
Other After Tax Income (Expense)
8,199.00
-
-
-
-
-

About Xenon Pharmaceuticals

View Profile
Address
3650 Gilmore Way
Burnaby British Columbia V5G 4W8
Canada
Employees -
Website http://www.xenon-pharma.com
Updated 07/08/2019
Xenon Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in discovering and developing a pipeline of differentiated therapeutics. It has built a core enabling discovery platform for the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.